mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.4 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.03 |
0.4 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.4 |
mRNA |
BRD-K96970199 |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.4 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.032 |
0.4 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
-0.031 |
0.4 |